Medicare Advantage Prior Auth Denial Rates: What Behavioral Health Practices Need to Know (2026)

The Scope of the Problem: MA Plans and Behavioral Health Denials

The evidence base for Medicare Advantage prior authorization over-denial is extensive and damning. Multiple HHS Office of Inspector General investigations have documented that MA plans systematically deny services that traditional Medicare would cover, and behavioral health services are among the most affected categories.

OIG Findings on MA Prior Authorization Denials

The OIG's landmark 2022 report (OEI-09-18-00260) examined a sample of MA plan prior authorization denials and found that 13% of denied requests met Medicare coverage criteria and should have been approved. A subsequent OIG analysis focusing on specific service categories found even higher inappropriate denial rates for behavioral health services, post-acute care, and specialty referrals.

For behavioral health specifically, the pattern of over-denial is well-documented across several service categories:

• Residential treatment (ASAM Level 3.5-3.7): MA plans frequently deny residential SUD treatment after a fixed number of days regardless of clinical progress, applying rigid length-of-stay criteria rather than individualized medical necessity review. Denial rates for residential treatment extensions at some MA plans reach 25% to 35%.
• Partial hospitalization programs (PHP): PHP authorization denials are common when MA plans use narrow clinical criteria that do not account for the full spectrum of patients who benefit from structured day programming. Plans may deny PHP when a patient is "stable enough for IOP" based on a single clinical parameter while ignoring co-occurring conditions, housing instability, or safety concerns.
• Intensive outpatient programs (IOP): IOP denials often occur at the concurrent review stage when plans determine that a patient has met initial treatment goals without evaluating whether ongoing IOP is necessary for relapse prevention or continued stabilization.
• Outpatient therapy beyond initial sessions: Some MA plans impose soft caps on outpatient therapy sessions, requiring prior authorization after a set number of visits (typically 12 to 20 sessions). Requests for continued therapy are denied at higher rates than initial authorization requests, forcing patients to either self-pay for continued treatment or discontinue care.

Why BH Services Are Disproportionately Denied

Several structural factors contribute to disproportionate denial rates for behavioral health services:

• Subjective clinical criteria: Unlike a broken bone or a tumor that can be imaged, behavioral health conditions involve subjective clinical assessments. MA plans exploit this subjectivity by requiring documentation of specific symptom severity scores, functional impairment measures, or risk levels that may not match how treating clinicians document in practice.
• Proprietary criteria that exceed Medicare standards: MA plans frequently use proprietary clinical guidelines from organizations like InterQual (Change Healthcare) and MCG (Hearst Health) that impose stricter requirements than Medicare National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). CMS has explicitly stated that MA plans cannot apply criteria more restrictive than traditional Medicare, but enforcement has been inconsistent.
• Concurrent review as a denial tool: Unlike services that require a single upfront authorization, many behavioral health services require ongoing concurrent review. Each review is a new opportunity for the plan to deny continued authorization, and the administrative burden of repeated reviews discourages providers from continuing care even when clinically warranted.
• Low appeal rates: Behavioral health providers appeal denied authorizations at lower rates than providers in other specialties, in part because of smaller practice sizes, limited administrative staff, and the time sensitivity of behavioral health crises. MA plans benefit financially from denials that are not appealed.

CMS-0057-F: The New Transparency Rules

The CMS Interoperability and Prior Authorization final rule (CMS-0057-F, published January 2024) represents the most significant regulatory response to MA prior authorization abuse. The rule requires MA plans (and other payers) to publicly report prior authorization metrics, giving providers and patients unprecedented visibility into plan performance. For details on how the broader prior authorization reform timelines affect behavioral health, see our CMS Prior Auth Reform 2026 guide.

What MA Plans Must Report

Under CMS-0057-F, MA plans must publicly report the following metrics:

• Prior authorization denial rates by service category: Plans must disclose the percentage of PA requests denied for each service type, including behavioral health categories. This allows providers to see, for example, that Plan A denies 28% of PHP authorizations while Plan B denies only 12%.
• Average decision turnaround times: Plans must report how long they take, on average, to process PA requests. CMS has set maximum timeframes (72 hours for urgent requests, 7 calendar days for standard requests under the new requirements), and the reported data will show which plans routinely approach or exceed these limits.
• Appeal overturn rates: Plans must disclose the percentage of denied PA requests that are overturned on appeal. A high overturn rate is a strong indicator that the plan's initial denial criteria are too restrictive. An overturn rate above 50% for a service category suggests that the plan is systematically denying services that should be approved.
• Clinical criteria used for PA decisions: Plans must make their clinical criteria publicly available, allowing providers and patients to understand what documentation and clinical thresholds the plan applies. This eliminates the "black box" problem where providers did not know why a request was denied until after the denial was issued.

How to Use Public PA Data

This transparency data creates several strategic opportunities for behavioral health practices:

• Identify high-denial plans before they become a problem: When evaluating whether to contract with a new MA plan or renew an existing contract, pull the plan's PA denial data for behavioral health categories. If the plan shows denial rates significantly above the industry average for your services, factor that into the contract decision. A plan offering favorable per-session rates but denying 30% of PHP authorizations may produce less net revenue than a plan with lower rates but a 10% denial rate.
• Strengthen appeal arguments: When appealing a denied PA, reference the plan's own publicly reported data. If the plan's appeal overturn rate for behavioral health services is 55%, state this in the appeal letter. It demonstrates that the plan's own data shows its initial denials are unreliable and that the appeal should be given full consideration.
• Support contract negotiations: Use PA data as leverage in contract negotiations. If a plan's behavioral health denial rate is 25% while the market average is 15%, present this data during rate negotiations and request either improved PA approval processes or higher reimbursement rates to compensate for the administrative burden and lost revenue from over-denial.
• Escalate to CMS: When public data reveals a pattern of over-denial, file a complaint with CMS. CMS tracks plan performance through Star Ratings, and documented patterns of inappropriate denials affect a plan's rating. Plans are financially motivated to maintain high Star Ratings because ratings affect enrollment and bonus payments.

CMS Audit Findings: When MA Plans Violate Coverage Rules

CMS conducts annual audits of MA plan compliance with Medicare coverage requirements, and the findings consistently show that many plans apply prior authorization criteria that are stricter than traditional Medicare standards. This is not a gray area: CMS regulations (42 CFR 422.101) require MA plans to cover all items and services that are covered under original Medicare Parts A and B, and plans cannot impose additional coverage criteria that effectively deny services that traditional Medicare would approve.

Specific CMS audit findings relevant to behavioral health include:

• Use of proprietary length-of-stay guidelines: CMS has cited MA plans for using proprietary length-of-stay guidelines for inpatient psychiatric and residential treatment that are shorter than what clinical evidence supports and shorter than what traditional Medicare would approve.
• Requiring specific assessment tools not required by Medicare: Some MA plans require specific standardized assessment scores (such as PHQ-9 below a certain threshold or ASAM criteria at a specific level) as a condition of authorization, even when traditional Medicare does not impose these specific assessment requirements. While clinical assessments are appropriate, requiring specific tools as a binary approval/denial criterion goes beyond Medicare standards.
• Denying concurrent reviews without clinical review: CMS has found that some MA plans use automated systems to deny concurrent review requests when they fall outside preset parameters, without individualized clinical review by a qualified reviewer. This practice violates CMS requirements for individualized medical necessity determinations.
• Failure to provide timely decisions: MA plans are required to make prior authorization decisions within specific timeframes. CMS audits have found that plans frequently exceed these timeframes for behavioral health services, effectively creating authorization gaps that disrupt patient care and create billing problems.

Appeal Strategies Specific to Behavioral Health

Effective appeals for behavioral health prior authorization denials require a different approach than appeals for medical or surgical services. The following strategies are specific to the behavioral health context:

Documentation for Clinical Necessity

The appeal must establish medical necessity using the patient's specific clinical presentation, not generic statements. Effective documentation includes:

• Current symptom severity with specific measures: Include validated assessment scores (PHQ-9, GAD-7, Columbia Suicide Severity Rating Scale, AUDIT-C, DAST-10) with dates and trends showing that treatment is needed and that the requested level of care is appropriate.
• Functional impairment documentation: Describe specific functional limitations in concrete terms: the patient cannot maintain employment, cannot perform ADLs independently, is unable to maintain housing stability, or has specific safety concerns that require the requested level of care.
• ASAM criteria alignment for SUD services: For substance use disorder services, map the patient's assessment to ASAM criteria dimensions and show that the requested level of care matches ASAM placement recommendations. Many MA plans use ASAM criteria as their reference framework, and demonstrating clear ASAM alignment strengthens the appeal significantly.
• Treatment response and progress documentation: For concurrent review denials, show that the patient is responding to treatment (symptom reduction, improved functioning) but has not yet reached a level of stability sufficient for safe step-down. Include specific clinical milestones the patient has achieved and specific goals remaining.
• Risk documentation: Clearly document the clinical risk if the requested service is denied. What happens if the patient is stepped down from PHP to IOP prematurely? What is the relapse risk if residential treatment is discontinued? Use clinical evidence and the patient's history to make this risk concrete.

Peer-to-Peer Review Tactics

Peer-to-peer reviews are often the most effective opportunity to overturn a behavioral health denial. The following approach maximizes success:

1. Ensure the treating clinician conducts the call. The physician, psychologist, or licensed clinician who is treating the patient should conduct the peer-to-peer call, not billing staff or utilization review coordinators. The treating clinician can speak to the patient's clinical presentation with specificity and authority that administrative staff cannot.
2. Review the denial reason before the call. Obtain the specific denial reason and the clinical criteria the plan applied. Prepare a point-by-point response to each criterion that was not met, with clinical evidence showing that the criterion is either met or that the plan's criterion is stricter than Medicare coverage criteria.
3. Prepare a 2-minute clinical summary. Open the peer-to-peer call with a concise summary: diagnosis, current symptom severity, functional status, treatment plan, progress to date, and specific reason the requested level of care is necessary. Do not ramble; the plan's reviewer has a limited time slot and will be more receptive to a structured presentation.
4. Challenge inappropriate criteria directly. If the plan's reviewer cites a criterion that is stricter than Medicare coverage standards or that contradicts published clinical guidelines (APA Practice Guidelines, ASAM Criteria), state this directly. For example: "The plan is requiring a PHQ-9 below 10 for PHP authorization, but Medicare coverage criteria for PHP do not impose a specific PHQ-9 threshold, and APA guidelines support PHP for patients across a range of symptom severity levels."
5. Document everything. After the call, document the reviewer's name and credentials, the date and time, what was discussed, and any verbal commitments. If the reviewer states they will approve or that they need additional documentation, document this in writing and follow up.

Escalating Beyond the Plan

When internal appeals fail, behavioral health providers have external escalation options:

• External review through an Independent Review Entity (IRE): MA beneficiaries have the right to request an independent external review of denied services. The IRE reviews the case de novo and can overturn the plan's denial. IRE overturn rates for behavioral health services are significantly higher than MA plan internal appeal overturn rates.
• CMS complaint: File a complaint with CMS through 1-800-MEDICARE or the CMS MA complaint form. CMS tracks complaints by plan and service type, and patterns of complaints affect Star Ratings and trigger targeted audits.
• State insurance commissioner complaint: In states that regulate MA supplemental benefits or that have adopted additional patient protection laws, complaints to the state insurance commissioner can trigger plan-level investigations.
• Congressional inquiry: For patterns of denial affecting multiple patients at a single plan, a congressional inquiry through the beneficiary's representative can prompt CMS to investigate the plan's behavioral health authorization practices.

What Your Billing Team Needs to Do

These action items translate the regulatory landscape into concrete operational steps for behavioral health RCM teams:

1. Pull and analyze MA denial reports by plan and service type. Run denial reports for the past 12 months segmented by MA plan and by service category (outpatient therapy, PHP, IOP, residential, psychiatric evaluation, medication management). Calculate the denial rate for each plan-service combination. Identify which plans have denial rates above 15% for any behavioral health service category. These are the plans that require focused attention.
2. Calculate the financial impact of MA denials. For each high-denial plan, multiply the number of denied authorizations by the average expected reimbursement per authorization. This gives you the gross revenue impact. Then subtract the revenue recovered through successful appeals. The difference is your net revenue loss to preventable denials. Present this analysis to practice leadership because it quantifies the ROI of investing in appeal capacity.
3. Build standardized appeal templates for common BH denials. Create appeal letter templates for the most common denial scenarios: PHP step-down denial, IOP concurrent review denial, residential extension denial, outpatient therapy session limit denial, and psychiatric medication management authorization denial. Each template should include placeholders for patient-specific clinical data, pre-written sections citing Medicare coverage criteria and clinical guidelines, and reference to the plan's own denial and overturn rate data (from CMS-0057-F reporting).
4. Establish a peer-to-peer review protocol. Create a standardized protocol for peer-to-peer reviews that includes scheduling the call within the required timeframe, pre-call preparation (reviewing the denial reason, pulling clinical documentation, preparing the 2-minute summary), ensuring the treating clinician conducts the call, and post-call documentation and follow-up. Track peer-to-peer outcomes by plan and clinician to identify which approaches are most effective.
5. Monitor CMS-0057-F public reporting data. As MA plans begin publishing PA metrics under CMS-0057-F, assign a staff member to monitor this data quarterly. Create a dashboard comparing your contracted MA plans' behavioral health denial rates, decision timelines, and overturn rates. Use this data in contract renewal discussions and in appeal correspondence.
6. Escalate to CMS when plans violate PA timeline rules. Track PA decision turnaround times for each MA plan. When a plan fails to meet the required timeline (72 hours for urgent requests, 7 calendar days for standard requests), document the violation and file a CMS complaint. Systematic timeline violations indicate plan-level non-compliance that CMS will investigate.
7. Use denial data in contract negotiations. When negotiating or renewing MA plan contracts, present your denial rate analysis alongside the plan's publicly reported data. If the plan's behavioral health denial rate exceeds the industry average, negotiate for streamlined PA processes, reduced PA requirements for specific service types, or higher reimbursement rates to offset the administrative cost of managing excessive PA requirements.
8. Train clinical staff on authorization-friendly documentation. Many denials originate from clinical documentation that does not address the plan's specific authorization criteria. Train therapists, psychiatrists, and counselors to include specific elements in their notes: validated assessment scores, functional impairment descriptions, safety risk documentation, ASAM criteria mapping for SUD services, and explicit medical necessity statements. This is not about gaming the system; it is about ensuring that the clinical information the plan needs to approve the service is actually present in the documentation.

Revenue and Financial Impact

The financial impact of MA prior authorization denials on behavioral health practices is substantial and often underestimated because practices do not systematically track it.

The cost of MA denials goes beyond direct revenue loss:

• Administrative cost of the PA process: Industry data estimates that behavioral health practices spend 15 to 25 hours per week on prior authorization activities per full-time clinician. At a fully loaded cost of $35 to $50 per hour for administrative staff, the annual PA administrative cost per clinician ranges from $27,000 to $65,000. For a practice with 10 clinicians, the total PA administrative cost approaches $270,000 to $650,000 per year.
• Clinical time diverted from patient care: When clinicians conduct peer-to-peer reviews, prepare clinical summaries for appeals, and complete prior authorization request forms, that time is not available for billable patient care. A psychiatrist spending 3 hours per week on PA activities at a billable rate of $250 per hour represents $39,000 in annual opportunity cost.
• Patient attrition from delayed care: When prior authorization delays prevent patients from starting treatment promptly, some patients disengage entirely. For a PHP program where a 5-day authorization delay causes 10% of referred patients to drop out, the revenue impact is compounded by the clinical harm of untreated behavioral health conditions.
• Positive ROI of appeal investment: Despite the costs, systematic appeals produce positive ROI. If a practice successfully appeals 60% of denied MA authorizations with an average value of $5,000 each and processes 100 denials per year, the recovered revenue is $300,000, far exceeding the staff cost of managing the appeal process.

EHR and Technology Implications

Managing MA prior authorization effectively at scale requires EHR and practice management systems that support the entire PA lifecycle, from initial request through appeal and escalation. The following capabilities are critical for behavioral health practices.

• Integrated prior authorization tracking: The EHR should track every PA request from submission through decision, including the plan, service type, submission date, decision date, outcome, and any appeal activity. This data is essential for calculating denial rates by plan and identifying patterns. EHR platforms built for behavioral health, including AZZLY Rize and Ease, provide integrated PA tracking dashboards that surface denial trends by payer and service line, enabling practices to identify problem plans before cumulative revenue loss becomes severe.
• Authorization-aware scheduling: The EHR should prevent scheduling services that require prior authorization until the authorization is confirmed. This avoids the scenario where a patient receives treatment, the PA is denied, and the practice is left with an unbillable service. Authorization-aware scheduling is particularly important for PHP and IOP programs where patients attend multiple sessions per week.
• Clinical documentation templates for authorization support: EHR templates should prompt clinicians to include the specific clinical elements that MA plans require for authorization: validated assessment scores, functional status measures, safety risk documentation, ASAM criteria mapping, and explicit medical necessity statements. Templates that guide clinicians to include these elements at the point of care reduce the likelihood of denials caused by insufficient documentation.
• Appeal workflow management: The EHR should support a structured appeal workflow that tracks appeal deadlines, generates appeal letters from clinical documentation, routes peer-to-peer review requests to the treating clinician, and logs appeal outcomes. Automated deadline tracking is critical because missing an appeal filing deadline forfeits the provider's appeal rights.
• Denial analytics and reporting: The EHR should produce reports showing denial rates by MA plan, service type, denial reason, appeal outcome, and financial impact. These reports enable data-driven contract negotiations, targeted clinical documentation improvement, and strategic decisions about which MA plans to participate with.
• Electronic PA submission: CMS-0057-F requires MA plans to support electronic prior authorization through FHIR-based APIs by 2027. EHR systems that support electronic PA submission will reduce administrative time significantly compared to phone- and fax-based PA processes. Practices should verify that their EHR vendor is building or has built FHIR-based PA capabilities.

Frequently Asked Questions

What percentage of Medicare Advantage prior authorizations are denied?

According to HHS Office of Inspector General reports, Medicare Advantage plans deny approximately 13% to 18% of prior authorization requests that would have been approved under traditional Medicare. For behavioral health services specifically, denial rates are often higher, with residential treatment, PHP, and IOP facing denial rates of 20% to 30% at some MA plans. The OIG has found that a significant portion of these denials are based on clinical criteria stricter than Medicare coverage criteria, which violates CMS requirements.

What is CMS-0057-F and how does it affect prior authorization transparency?

CMS-0057-F is the Interoperability and Prior Authorization final rule that requires MA plans to publicly report prior authorization metrics including denial rates by service category, average decision turnaround times, appeal overturn rates, and the clinical criteria used for PA decisions. Requirements phase in starting 2026, with full reporting by 2027. For behavioral health practices, this data allows providers to identify high-denial plans, compare plan performance, support appeals with evidence, and use denial data in contract negotiations.

Can Medicare Advantage plans use clinical criteria stricter than traditional Medicare for behavioral health?

No. CMS requires that MA plans cover all services covered under traditional Medicare, and plans cannot apply criteria more restrictive than Medicare National Coverage Determinations and Local Coverage Determinations. However, OIG audits have repeatedly found plans using proprietary clinical guidelines (InterQual, MCG) that impose stricter requirements. When a provider believes a plan is applying criteria stricter than traditional Medicare, the provider should document this in the appeal and cite the specific Medicare coverage criteria that the plan's decision contradicts.

How should behavioral health practices prepare for peer-to-peer reviews with MA plans?

The treating clinician should conduct the call, not billing staff. Prepare by reviewing the specific denial reason and the plan's clinical criteria beforehand, preparing a concise clinical summary that addresses each denial criterion, citing ASAM criteria for SUD services or APA practice guidelines for mental health services, documenting medical necessity using the patient's specific clinical presentation, and noting safety risks if treatment is denied. After the call, document the conversation in detail including the reviewer's name, credentials, and commitments made.

How much revenue do behavioral health practices lose to Medicare Advantage denials?

Industry analyses estimate that the average behavioral health practice with a significant MA payer mix loses between $80,000 and $200,000 annually to preventable denials. For larger organizations operating residential, PHP, and IOP programs, losses can reach $500,000 or more per year. These estimates include both direct revenue loss and indirect costs: staff time on PA requests and appeals, delayed treatment causing patient attrition, and clinical documentation time diverted from patient care. Many practices do not systematically track MA denial costs, making the true financial impact invisible until a formal analysis is conducted.

What recourse do providers have when MA plans violate prior authorization timeline rules?

When MA plans fail to meet required decision timelines (72 hours for urgent requests, 7 calendar days for standard requests), providers should document the violation with dates and communication records, file a complaint with CMS, include the timeline violation in subsequent appeals, escalate to the plan's provider relations department in writing, and for patterns of violations, file a complaint with the state insurance commissioner. CMS has increased penalties for systematic timeline failures, and documented violations create leverage in contract negotiations.

Editorial Standards

Last reviewed: February 26, 2026

Methodology

• HHS Office of Inspector General reports on Medicare Advantage prior authorization practices reviewed for denial rate data and findings
• CMS-0057-F final rule text analyzed for transparency and reporting requirements applicable to behavioral health
• CMS MA compliance audit findings reviewed for behavioral health-specific citations and enforcement patterns
• Industry revenue cycle data analyzed for financial impact estimates on behavioral health practices
• ASAM criteria and APA practice guidelines cross-referenced against common MA plan clinical criteria for appeal strategy development

Primary Sources

• HHS OIG: Some Medicare Advantage Organization Denials of Prior Authorization Requests (OEI-09-18-00260)
• CMS: Interoperability and Prior Authorization Final Rule (CMS-0057-F)
• CMS: Medicare Advantage and Part D Star Ratings
• Federal Register: Medicare Advantage Prior Authorization Requirements
• HHS OIG: Medicare Advantage Appeal Outcomes and Audit Findings